[Retracted] CIP2A, an oncoprotein, is associated with cell proliferation, invasion and migration in laryngeal carcinoma cells

Subsequently to the publication of the above paper, an interested reader has drawn to our attention that five pairs of data panels in Fig. 3A and B, showing the results of Transwell invasion and migration assay experiments, were overlapping, such that data which were intended to show the results from a number of differently performed experiments had apparently been derived from the same original sources. Following an independent assessment of these data in the Editorial Office, the Editor of <i>Oncology Reports</i> has decided that this article should be retracted from the publication on account of a lack of confidence in the integrity of the presented data. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused by the retraction of this article.[Oncology Reports 38: 1005‑1012, 2017; DOI: 10.3892/or.2017.5759].

Authors

Institutions

Publication Details

Journal
Oncology Reports
Published
2025-02-06
DOI
https://doi.org/10.3892/or.2025.8875
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[Retracted] CIP2A, an oncoprotein, is associated with cell proliferation, invasion and migration in laryngeal carcinoma cells

Shixiong Tang, Yao-wen Wang, Xudong Chen, Jianhua Zhang et al.
Oncology Reports
Lung Cancer Treatments and Mutations
article

[Retracted] CIP2A, an oncoprotein, is associated with cell proliferation, invasion and migration in laryngeal carcinoma cells

Shixiong Tang, Yao-wen Wang, Xudong Chen, Jianhua Zhang, Litao Zhang
article en

Abstract

Subsequently to the publication of the above paper, an interested reader has drawn to our attention that five pairs of data panels in Fig. 3A and B, showing the results of Transwell invasion and migration assay experiments, were overlapping, such that data which were intended to show the results from a number of differently performed experiments had apparently been derived from the same original sources. Following an independent assessment of these data in the Editorial Office, the Editor of <i>Oncology Reports</i> has decided that this article should be retracted from the publication on account of a lack of confidence in the integrity of the presented data. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused by the retraction of this article.[Oncology Reports 38: 1005‑1012, 2017; DOI: 10.3892/or.2017.5759].

Oncology ReportsVol. 53(4)
Ningbo First Hospital (CN)
Openalex Percentile: Top 97%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.